Andrew Levin

Managing Partner · RA Capital

Decision makerActive

Email

Verified, deliverable email

Unlock Andrew and the rest of RA Capital

One payment, no subscription - every verified contact at RA Capital drops into your wallet.

Stages: Seed, Pre-seed
Sectors: Health tech
Freshness: Verified today
Fund size: $308.2M

Notable investments

Slate MedicinesSeries A · $130M · 2026
Imbria PharmaceuticalsSeries B · $67M · 2025
Alchemab TherapeuticsSeries A · $32M · 2025
Pahr TherapeuticsSeed · $14M · 2025
Aktis OncologySeries B · $180M · 2024
Superluminal MedicinesSeries A · $120M · 2024
Navigator MedicinesSeries A · $100M · 2024
Climb BioPost Ipo Equity · $120M · 2024

Frequently co-invests with

Cindy XiongForesite CapitalDylan MorrisInsight PartnersHouman AshrafianSV Health InvestorsJason Ruth5am VenturesKate BinghamSV Health InvestorsLiam RatcliffeAccess BiotechnologyOhad HammerPontifax Venture CapitalTodd FoleyMPM CapitalWouter JoustraForbion

Andrew Levin's colleagues at RA Capital

Every verified colleague at RA Capital

One payment, no subscription - they all drop into your wallet.

Daniel BahcheliAssociate, RA Capital

Zach ScheinerPrincipal, RA Capital

Anthony ArceciAssociate, RA Capital

Reza HalsePartner, RA Capital

Derek DiRoccoPartner, RA Capital

Jake SimsonPartner, RA Capital

Laura StoppelPrincipal, RA Capital

Peter KolchinskyManaging Partner, RA Capital

Rajeev ShahManaging Director, RA Capital

Anurag KondapalliPrincipal, RA Capital

Cristina GhenoiuPrincipal, RA Capital

See all 12 at RA Capital →

Related lists

Health tech investors

Similar investors

Raffi KamberGeneral Partner, Singular

Prachi SinhaInvestor, Axilor Ventures

Blake PateAnalyst, Bios Partners

Przemek OblojManaging Partner, Blue Horizon

Prashant NarangPartner, Fluid Ventures

Pierre SochaPartner, Amadeus Capital Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Andrew Levin? Request removal of this listing.